These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1.
    Author: Held W, Kunz B, Lowin-Kropf B, van de Wetering M, Clevers H.
    Journal: Immunity; 1999 Oct; 11(4):433-42. PubMed ID: 10549625.
    Abstract:
    Families of clonally expressed major histocompatibility complex (MHC) class I-specific receptors provide specificity to and regulate the function of natural killer (NK) cells. One of these receptors, mouse Ly49A, is expressed by 20% of NK cells and inhibits the killing of H-2D(d) but not D(b)-expressing target cells. Here, we show that the trans-acting factor TCF-1 binds to two sites in the Ly49A promoter and regulates its activity. Moreover, we find that TCF-1 determines the size of the Ly49A NK cell subset in vivo in a dosage-dependent manner. We propose that clonal Ly49A acquisition during NK cell development is regulated by TCF-1.
    [Abstract] [Full Text] [Related] [New Search]